-
公开(公告)号:HU224211B1
公开(公告)日:2005-06-28
申请号:HU9503932
申请日:1995-12-29
Applicant: HOECHST AG
Inventor: CRAUSE PETER DR , KAISER JOACHIM DR , ENGLERT HEINRICH DR , GOEGELEIN HEINZ DR , MANRIA DIETER DR , GERLACH UWE DR
IPC: C07D333/20 , A61K31/18 , A61K31/34 , A61K31/35 , A61K31/38 , A61K31/381 , A61K31/395 , A61K31/40 , A61K31/425 , A61K31/426 , A61K31/64 , A61P9/00 , A61P9/04 , A61P9/06 , A61P9/10 , C07C233/00 , C07C303/40 , C07C311/58 , C07C327/40 , C07C335/42 , C07D207/32 , C07D207/335 , C07D213/40 , C07D277/28 , C07D307/52 , C07C311/51
Abstract: Substd. benzenesulphonylurea or -thiourea cpds. of formula (I) are new: R1 = H, 1-6C alkyl, or 3-6C cycloalkyl; R2 = 1-6C alkyl, 1-6C alkoxy, 1-6C mercaptoalkyl, 3-6C cycloalkyl, or a 1-8C chain in which 1-3C may be replaced by O, NH or S; R3, R4 = H or 1-6C alkyl; or R3 + R4 = (CH2)p; p = 2-5; E, X = O or S; Y = ÄC(R5)2Üm; R5 = H, Me or Et; m = 1 or 2; Ar = phenyl, thienyl, furyl, pyrrolyl, thiazolyl, naphthyl or pyridyl (all opt. substd. by 1-3 Me, Et, MeO, EtO, Cl, Br or F).
-
公开(公告)号:DK0729954T3
公开(公告)日:2003-12-01
申请号:DK96101096
申请日:1996-01-26
Applicant: HOECHST AG
Inventor: ENGLERT HEINRICH DR , HARTUNG JENS DR , CRAUSE PETER DR , MANIA DIETER DR , GOEGELEIN HEINZ DR , KAISER JOACHIM DR
IPC: A61K31/38 , A61K31/381 , A61K31/64 , A61P9/00 , A61P9/04 , A61P9/06 , A61P9/10 , A61P43/00 , C07C335/00 , C07D333/34
Abstract: N-((2-Benzamidoethyl)- thiophene-sulphonyl)-urea or-thiourea derivs. of formula (I) are new. R1 = H, halogen, Me, Et, OMe, OEt, SMe, SEt, 1-2C fluoroalkyl or 1-2C fluoroalkoxy; X = O or S; R2 = H, Me or CF3; Y, Z = H, F, Cl, Br, I, Me, Et, OMe or OEt.
-
公开(公告)号:CZ290809B6
公开(公告)日:2002-10-16
申请号:CZ38296
申请日:1996-02-08
Applicant: HOECHST AG
Inventor: ENGLERT HEINRICH DR , GERLACH UWE DR , CRAUSE PETER DR , MANIA DIETER DR , GOGELEIN HEINZ DR , KAISER JOACHIM DR
IPC: C07D333/20 , A61K31/18 , A61K31/34 , A61K31/35 , A61K31/38 , A61K31/381 , A61K31/395 , A61K31/40 , A61K31/425 , A61K31/426 , A61K31/64 , A61P9/00 , A61P9/04 , A61P9/06 , A61P9/10 , C07C233/00 , C07C303/40 , C07C311/58 , C07C327/40 , C07C335/42 , C07D207/32 , C07D207/335 , C07D213/40 , C07D277/28 , C07D307/52
Abstract: In the present invention, there are disclosed substituted benzenesulfonyl ureas and benzenesulfonyl thioureas of the general formula I. These compounds as well as their pharmaceutically acceptable salts are valuable medicaments that are suitable not only as antiarrhythmic but also as compounds used for prophylaxis of cardiovascular system disorders, heart insufficiency, heart transplantations or cerebral vascular diseases in humans or animals.
-
公开(公告)号:CY2118B1
公开(公告)日:2002-04-26
申请号:CY9800036
申请日:1998-09-29
Applicant: HOECHST AG
Inventor: LANG HANS-JOCHEN DR , WEICHERT ANDREAS DR , KLEEMANN HEINZ-WERNER DR , ENGLERT HEINRICH DR , ALBUS UDO DR
IPC: A61K31/00 , A61K31/155 , A61K31/445 , A61P1/16 , A61P9/00 , A61P9/06 , A61P9/08 , A61P9/10 , A61P9/12 , A61P13/02 , A61P15/00 , A61P35/00 , C07C311/16 , C07C311/21 , C07C311/29 , C07C317/24 , C07C317/44 , C07C317/46 , C07C317/48 , C07C323/22 , C07C323/65 , C07D211/14 , C07D211/70 , C07D295/14 , C07D295/155 , A61K31/54 , A61K31/45 , A61K49/00
Abstract: The invention relates to benzoylguanidines of the formula I where R(1) or R(2) is equal to R(3)-S(O)n- or R(4)R(5)N-O2S- and the other substituent R(1) or R(2) is in each case equal to H, OH, F, Cl, Br, I, alkyl, alkoxy, benzyloxy or phenoxy, R(3)-S(O)n or R(4)R(5)N- or 3,4-dehydropiperidine and R(3) is equal to alkyl, cycloalkyl, cyclopentylmethyl, cyclohexylmethyl or phenyl, R(4) and R(5) are equal to alkyl or phenylalkyl or phenyl, and in which R(4) and R(5) together can also be a C4-C7-chain, and in which R(4) and R(5), together with the nitrogen atom to which they are bonded, can denote a dihydroindol, tetrahydroquinoline or tetrahydroisoquinoline system, and where n is equal to zero, 1 or 2 and their pharmaceutically tolerable salts are outstanding antiarrhythmic agents. They are obtained by a process in which compounds of the formula II in which X stands for a leaving group which can be easily nucleophilically substituted, are reacted with guanidine.
-
公开(公告)号:DE59606062D1
公开(公告)日:2000-12-07
申请号:DE59606062
申请日:1996-02-05
Applicant: HOECHST AG
Inventor: ENGLERT HEINRICH DR , GERLACH DR , CRAUSE DR , MANIA DR , GOEGELEIN DR , KAISER DR
IPC: C07D333/20 , A61K31/18 , A61K31/34 , A61K31/35 , A61K31/38 , A61K31/381 , A61K31/395 , A61K31/40 , A61K31/425 , A61K31/426 , A61K31/64 , A61P9/00 , A61P9/04 , A61P9/06 , A61P9/10 , C07C233/00 , C07C303/40 , C07C311/58 , C07C327/40 , C07C335/42 , C07D207/32 , C07D207/335 , C07D213/40 , C07D277/28 , C07D307/52
Abstract: Substd. benzenesulphonylurea or -thiourea cpds. of formula (I) are new: R1 = H, 1-6C alkyl, or 3-6C cycloalkyl; R2 = 1-6C alkyl, 1-6C alkoxy, 1-6C mercaptoalkyl, 3-6C cycloalkyl, or a 1-8C chain in which 1-3C may be replaced by O, NH or S; R3, R4 = H or 1-6C alkyl; or R3 + R4 = (CH2)p; p = 2-5; E, X = O or S; Y = ÄC(R5)2Üm; R5 = H, Me or Et; m = 1 or 2; Ar = phenyl, thienyl, furyl, pyrrolyl, thiazolyl, naphthyl or pyridyl (all opt. substd. by 1-3 Me, Et, MeO, EtO, Cl, Br or F).
-
公开(公告)号:GR3029768T3
公开(公告)日:1999-06-30
申请号:GR990400855
申请日:1999-03-23
Applicant: HOECHST AG
Inventor: ENGLERT HEINRICH DR , MANIA DIETER DR , HARTUNG JENS DR , GOEGELEIN HEINZ DR , KAISER JOACHIM DR
IPC: A61K31/64 , A61P9/06 , A61P9/08 , A61P9/10 , C07C303/36 , C07C311/57 , C07C311/58 , C07C335/42 , C07D295/135
Abstract: Amino-substituted benzenesulphonylureas and -thioureas of the formula I are described. The compounds I are used for treating cardiac dysrhythmias and for preventing sudden heart death due to arrhythmias and can therefore be used as antiarrhythmics. They are particularly suitable for cases in which arrhythmias are the consequence of a constriction of a coronary vessel, such as in angina pectoris or acute myocardial infarct.
-
公开(公告)号:AT165351T
公开(公告)日:1998-05-15
申请号:AT91122406
申请日:1992-01-01
Applicant: HOECHST AG
Inventor: WAGNER ADALBERT DR , ENGLERT HEINRICH DR , KLEEMANN HEINZ-WERNER DR , GERHARDS HERMANN DR , SCHOELKENS BERNWARD PROF DR , BECKER REINHARD DR , LINZ WOLFGANG DR , CAILLE JEAN-CLAUDE , VEVERT JEAN-PAUL
IPC: A61K31/40 , A61K31/415 , A61K31/425 , A61K31/435 , A61K31/44 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/445 , A61K31/505 , A61K31/535 , A61K31/54 , A61K31/64 , A61P9/00 , A61P9/08 , A61P9/10 , A61P9/12 , A61P13/02 , A61P15/00 , A61P43/00 , C07D207/34 , C07D207/36 , C07D233/54 , C07D233/66 , C07D233/68 , C07D233/70 , C07D233/84 , C07D233/90 , C07D249/02 , C07D255/02 , C07D257/02 , C07D257/04 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07D417/12 , C07D453/02 , C07D521/00
Abstract: Azole derivative of the general formula (I) in which A, L, O, R , X, Y, Z and q have the meanings given, a process for their preparation, pharmaceutical preparations and the use of the compounds are described. Azole derivatives of the formula I where the symbols have, for example, the following meanings: R = (C2-C10)-alkyl Z = nitrogen X and Y = independently of one another CR L = -CH2- q = zero or 1 A = biphenyl radical which is substituted, for example, by R R = halogen or hydrogen R = SO2-NH-CO-OR and R = phenyl, are highly active antagonists of angiotensin II receptors.
-
公开(公告)号:CZ9600280A3
公开(公告)日:1998-04-15
申请号:CZ28096
申请日:1996-01-30
Applicant: HOECHST AG
Inventor: ENGLERT HEINRICH DR , HARTUNG JENS DR , CRAUSE PETER DR , MANIA DIETER DR , GOGELEIN HEINZ DR , KAISER JOACHIM DR
IPC: A61K31/38 , A61K31/381 , A61K31/64 , A61P9/00 , A61P9/04 , A61P9/06 , A61P9/10 , A61P43/00 , C07C335/00 , C07D333/34
CPC classification number: C07D333/34
-
公开(公告)号:DK0556672T3
公开(公告)日:1998-03-02
申请号:DK93101840
申请日:1993-02-05
Applicant: HOECHST AG
Inventor: LINZ WOLFGANG DR , SCHOLZ WOLFGANG DR , LANG HANS-JOCHEN DR , ENGLERT HEINRICH DR , ALBUS UDO DR , MANIA DIETER DR
IPC: A61K31/155 , A61K31/165 , A61K31/445 , A61P1/16 , A61P3/08 , A61P3/10 , A61P9/00 , A61P9/04 , A61P9/06 , A61P9/08 , A61P9/10 , A61P9/12 , A61P13/02 , A61P15/00 , A61P35/00 , C07C279/22 , C07D213/65 , C07D295/14 , C07D295/155
Abstract: There are described benzoylguanidines of the formula I in which R(1) or R(2) is an amino group -NR(3)R(4), where R(3) and R(4) are equal to H, (cyclo)alkyl or R(3) is equal to phenyl-(CH2)p- where p = 0, 1, 2, 3 or 4, or phenyl, or R(3) and R(4) together can also be a methylene chain, and in which the other substituent R(1) or R(2) in each case is H, F, Cl, alkyl, alkoxy, CF3, CmF2m+1-CH2-, benzyl or phenoxy, and their pharmaceutically tolerable salts. The compounds according to the invention have very good antiarrhythmic properties, such as they show, for example, in the case of oxygen deficiency symptoms. The compounds are used as antiarrhythmic medicaments having a cardioprotective component for infarct prophylaxis and infarct treatment and also for the treatment of angina pectoris, where they preventively inhibit or strongly decrease the pathophysiological processes during the formation of ischaemically induced damage, in particular during the induction of ischaemically induced cardiac arrhythmias.
-
公开(公告)号:CZ43696A3
公开(公告)日:1996-09-11
申请号:CZ43696
申请日:1996-02-14
Applicant: HOECHST AG
Inventor: ENGLERT HEINRICH DR , GERLACH UWE DR , MANIA DIETER DR , GOGELEIN HEINZ DR , KAISER JOACHIM DR
IPC: A61K31/18 , A61K31/64 , A61P9/00 , A61P9/04 , A61P9/06 , A61P9/10 , C07C233/00 , C07C303/40 , C07C311/58 , C07C311/59 , C07C327/40 , C07C335/42 , C07C311/54 , C07C303/36 , A61K31/17
Abstract: Substd. benzene sulphonyl urea and thiourea derivs. of formula (I) and their salts are new. R1 = H, Me or CF3; R2 = 4-10C alkoxy with 1-6C replaced by O, S or NH; Q = O or S; Y = ÄC(R3)2Üm; R3 = H, Me or Et; R' = H, halo or 1-6C alkyl; R" = halo, 1-4C alkoxy or 1-4C alkyl; and m = 1-4.
-
-
-
-
-
-
-
-
-